Quick answer In the research literature, the 50 mg GHK-Cu vial is generally reconstituted with 3 mL of bacteriostatic water, and documented research protocols reference roughly 1 mg per dose drawn from that reconstituted solution
If the FDA ultimately issues a final determination against listing, compounders would lose any viable legal pathway and substances could be re-nominated in future PCAC cycles, or challenged in court, as happened with previously restricted peptides
Exceeding 2,000mg per day may cause digestive upset, including bloating, loose stools, and cramping
However, the absence of large-scale human trials, FDA approval, and standardized sourcing means that patients should proceed with caution
These results highlight hepsin's crucial role in controlling APAP-induced liver toxicity by regulating the cellular abundance of GJ proteins, which can affect the transmission of toxic metabolites or cell death signals and potentially increase oxidative stress
